$DNLI News

Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026

Denali Therapeutics Q2 2026 Earnings Call Transcript

Is Denali Therapeutics (DNLI) Reasonably Valued On Future Cash Flow?

Is Denali Therapeutics (DNLI) Undervalued As Its Share Price Pullback Tests Fair Value?

Denali Therapeutics Inc. (DNLI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

B. Riley Securities Maintains Buy on Denali Therapeutics, Raises Price Target to $35

DNLI Stock Gains 33.1% in Three Months: Buy, Sell or Hold the Stock?

Denali Therapeutics: Bullish On Avlayah And Their Prospects

Denali Therapeutics (DNLI) Q2 2026 Earnings Call Transcript

Denali Therapeutics: AVLAYAH Converts A Platform Story Into A Commercial One

Denali Therapeutics (NASDAQ:DNLI) Shows Perfect Technical Setup for a Breakout

UBS Maintains Buy on Denali Therapeutics, Raises Price Target to $34

Denali Therapeutics Inc. Q2 2026 Earnings Call Summary

Denali Therapeutics Inc. (DNLI) Q2 2026 Earnings Call Transcript

Denali Therapeutics Inc. 2026 Q2 - Results - Earnings Call Presentation

Denali Therapeutics Q2 Earnings Call Highlights

Denali Therapeutics Inc. (DNLI) Reports Q2 Loss, Tops Revenue Estimates

Denali Therapeutics (NASDAQ:DNLI) Drops as Q2 AVLAYAH Revenue Misses Estimates

Denali Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights

Denali Therapeutics Q2 EPS $(0.68) Misses $(0.65) Estimate, Sales $3.604M Miss $14.613M Estimate